Wall Street brokerages expect Sharps Compliance Corp. (NASDAQ:SMED) to post sales of $12.86 million for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Sharps Compliance’s earnings. The lowest sales estimate is $12.69 million and the highest is $13.20 million. Sharps Compliance posted sales of $12.17 million in the same quarter last year, which would indicate a positive year over year growth rate of 5.7%. The firm is expected to announce its next quarterly earnings results on Wednesday, August 19th.
On average, analysts expect that Sharps Compliance will report full year sales of $51.42 million for the current financial year, with estimates ranging from $51.20 million to $51.80 million. For the next fiscal year, analysts forecast that the company will post sales of $57.68 million, with estimates ranging from $56.74 million to $59.50 million. Zacks’ sales averages are an average based on a survey of analysts that follow Sharps Compliance.
Sharps Compliance (NASDAQ:SMED) last announced its quarterly earnings results on Tuesday, April 28th. The industrial products company reported ($0.10) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by ($0.06). Sharps Compliance had a net margin of 1.16% and a return on equity of 2.18%. The business had revenue of $10.41 million during the quarter, compared to analyst estimates of $10.64 million. During the same period last year, the company earned ($0.07) EPS.
SMED has been the topic of several research analyst reports. Stifel Nicolaus boosted their price objective on Sharps Compliance from $6.00 to $9.00 and gave the company a “buy” rating in a report on Wednesday, April 8th. TheStreet downgraded Sharps Compliance from a “b-” rating to a “c” rating in a report on Thursday, May 14th. ValuEngine downgraded Sharps Compliance from a “buy” rating to a “hold” rating in a report on Friday, May 1st. Zacks Investment Research downgraded Sharps Compliance from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Finally, Barrington Research upped their price target on Sharps Compliance from $6.00 to $7.50 and gave the stock an “outperform” rating in a report on Thursday, April 30th. Two equities research analysts have rated the stock with a hold rating and four have given a buy rating to the company. The company presently has a consensus rating of “Buy” and an average price target of $6.10.
In other Sharps Compliance news, VP Dennis Halligan sold 13,500 shares of the stock in a transaction that occurred on Tuesday, May 19th. The stock was sold at an average price of $4.51, for a total transaction of $60,885.00. Following the completion of the sale, the vice president now directly owns 5,000 shares of the company’s stock, valued at approximately $22,550. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 16.50% of the stock is currently owned by company insiders.
Several hedge funds have recently modified their holdings of SMED. EAM Investors LLC increased its stake in Sharps Compliance by 123.4% in the 1st quarter. EAM Investors LLC now owns 307,699 shares of the industrial products company’s stock valued at $2,443,000 after purchasing an additional 169,970 shares in the last quarter. Cadence Capital Management LLC purchased a new position in Sharps Compliance in the 1st quarter valued at approximately $1,307,000. Globeflex Capital L P purchased a new position in Sharps Compliance in the 1st quarter valued at approximately $1,211,000. EAM Global Investors LLC purchased a new position in Sharps Compliance in the 1st quarter valued at approximately $998,000. Finally, ClariVest Asset Management LLC increased its stake in Sharps Compliance by 5,068.0% in the 1st quarter. ClariVest Asset Management LLC now owns 118,192 shares of the industrial products company’s stock valued at $938,000 after purchasing an additional 115,905 shares in the last quarter. 25.11% of the stock is owned by institutional investors and hedge funds.
Shares of Sharps Compliance stock traded down $0.45 during trading hours on Thursday, hitting $6.90. The company’s stock had a trading volume of 226,900 shares, compared to its average volume of 229,872. Sharps Compliance has a twelve month low of $3.38 and a twelve month high of $8.20. The firm has a fifty day moving average of $7.05 and a 200-day moving average of $5.90. The stock has a market cap of $112.82 million, a price-to-earnings ratio of 230.08, a P/E/G ratio of 23.97 and a beta of -0.79. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.42 and a current ratio of 1.85.
Sharps Compliance Company Profile
Sharps Compliance Corp. provides medical, pharmaceutical, and hazardous waste management services in the United States. It offers Sharps Recovery System for the containment, transportation, treatment, and tracking of medical waste and used healthcare materials generated outside the hospital and health care facility settings; TakeAway Medication Recovery System, a solution that facilitates the proper disposal of unused medications; MedSafe, a solution for the safe collection, transportation, and proper disposal of unwanted and expired prescription medications; and ComplianceTRAC, a Web-based compliance and training program.
Recommended Story: What are the Different Types of Leveraged Buyouts?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Sharps Compliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sharps Compliance and related companies with MarketBeat.com's FREE daily email newsletter.